Member Info for VikR

Stay long term invested vested astute investors.

As the market cap slowly rises big Pharma interest also piques accordingly.

Whilst I can appreciate people need to cash out because they might have met there target or need the funds, for those of you who can afford to hold your real rewards will come post RNS news. Then you can expect HUGE RE RATES in the SP many many multiples of where we are now

Someone somewhere has leaked some information and used this to top up pre RNS. Immoral behaviour on there behalf but I suppose we all benefit from the upward rise

RNS landing soon

The SP is waiting to go up steeply to its next step of 0.5. The optimism is building as the BOD continue to work diligently in the background across the portfolio. Any one of the assets have phenomenal potential and as a clinical end user I look forward to prescribing them one day.

There is still time to top up at this baseline

Stay vested astute investors

It is very important to exercise resilience during this time. This is not the true jump that will come on the imminent RNS’s for the valuable news that is coming. For those who may not be familiar with the science take some time to educate yourselves on the future proof tech that is being finalised. There is no known competitors for its capacity and capability to date.

Buy and then hold and use the time to research the science, it will furthermore reassure your decision.

For now I have topped up again another £5k

Stay vested astute investors

This has settled calmly now before going on a rigorous upward journey. Highly valuable commercial assets in the pipeline, in other UK science FAB fusion antibodies reaches on an intraday high to 15p on its way upto 30p as the new base. I hope these can both serve me well on the path to prosperity and more charitable donations to the needy

Stay vested astute investors

Topped up again with this need to see it fly now, also managed to catch FAB fusion antibodies from 8p to 14p with a projected first stop to 30p this week. Different fields but whether it’s biotech or natural gas, money is money and there is a sizeable chunk to be made in both

Stay vested astute investors

50p is good pitstop on the journey up to triple figures, once in a decade opportunity here. There must be so many CROs trying to scramble there way through to come even remotely close to the capability of Optimal

🚀🚀🧨🚀🚀

By now I hope all those invested can now appreciate the moves this makes with only 1 piece of news from many more news items due from validation to NCI to optiphage to optimal to DR5 to the next grant. Take your pick from the positives we have due, our CEO has throughly earned his admirable position here. He can use this to gracefully retire and enjoy the time with his family by the end of this year.

Remember there is little resistance to 30p

Stay level headed and remain grounded. Sell early and miss out for the bigger gains

Best of luck to everyone taking the opportunities

Hi I can see this is stabilising nicely as the seller moves out. Also great to see FAB fusion antibodies reach 14p intraday up from 6p a month ago on its way to 30p. Can see something similar with SVNS happening on some imminent RNS releases

UK scientific discoveries proud to be shining on the international platform. Well done to all the hard work and education of all these great scientists to make this happen

Stay vested astute investors

A few of my scientific colleagues have now piled in, didn’t need much convincing at all as once they delved in and researched if for themselves were blown away by the scientific capabilities of the optimal human immunome generator for novel antibody production.

Enjoy the unilateral upward trajectory

Stay vested astute investors

Nice to see fellow investors on the same train of thought, split my millions of shares between FAB fusion antibodies and SVNS both incredible potential for tremendous growth over the coming period

I spread the word to a few business associates who I know have money tucked away in high interest savings accounts. A few of them told me they liked the sound of FAB and would add a few to there portfolio. They usually invest in the thousands, will find out next time I touch base

Nice to see steady growth as it surpasses the 12p mark and remember the chart shows little resistance on its journey to 30p. Even then it will still be way undervalued. Commercial talks continue in the background so expect some surprise announcements to drop in the near term

Taking this opportunity to do another top up tomorrow

Stay vested astute investors

Yes you are correct yours is also a very viable route however with a sequencing capability of 10 to the 45 the extent of the library mimicking the human immunome does not exist in this world by any other CRO or alt provider alike. With lots of drugs coming off patent in the next few years big Pharma will have surplus funds to play around with and having the potential to work from your own library will be an excellent adjunct to possess.

Either way it’s a win win scenario

Sale of its stake I'm confident in that being the way this is heading

Good luck ALtHs

My train of thought concurs with this which is why I think before it starts to spread like wildfire 1 of the big Pharma are going to come in and take the lot. I just hope they let it go for excellent terms that rewards all vested shareholders

Either way it’s a win win scenario

Will keep on topping up the lower it goes and move funds from other shares to facilitate this. Making a sizeable position now so look forward to the rocket up when the golden RNS lands

Stay vested astute investors

There will be a strong exponential rise in the curve at some point and that will be worth while many multiples of 1p’s of increases. Only then are we beginning to anywhere near remotely the true value of this company and its portfolio assets. It cannot remain this low in this news critical era for too long. As with any astute investor get in before the rise of the curve rather then the peak. Alternatively if still unsure top up along the way, this is a dead cert now

With the patent now firmly secured big Pharma will be awake to this news and rushing to secure a deal. The final stages of validation are also being worked upon as confirmed by our CEO on the investor hub. This is aligning perfectly and as Adrian mentioned some months ago a little bit of luck was needed and now they have it with the perfect timing. So we now have patent with validation to follow and then a commercial deal to execute. LSE shares don’t get much better then a FAB play like this

Good luck all vested astute investors